ABLIM1 and neoplasm: Consistently, the p65, CCL20, and Ki-67 expressions in tumor xenografts were repressed after ABLIM1 knock-down (Fig. 4I), supporting ABLIM1 modulates the IĸBα/NF-κB/CCL20 axis to promote CRC progression.